Eyeing for JNJ stock? Know why J&J is splitting into 2 companies

November 12, 2021 09:53 AM PST | By Ipsita Sarkar
 Eyeing for JNJ stock? Know why J&J is splitting into 2 companies
Image source: vovidzha,Shutterstock

Highlights

  • Johnson & Johnson (NYSE:JNJ) announced to split into two companies within two years.

  • One will focus on drugs and medical devices, the other will focus on consumer products.

  • The company's sales surged 10.7% YoY to US$23.3 billion in the third quarter of FY21.

Healthcare company Johnson & Johnson (NYSE:JNJ) announced on Friday to split the business into two companies in the next two years, triggering a flurry of speculation in the market.

The stock jumped more than 2% in the premarket trading after the news.

The New Brunswick, New Jersey-based business conglomerate said one of the companies would deal with drugs and medical instruments, while the other would focus on consumer products.

Eyeing for J & J stock? Know why J&J is splitting into 2 companies

 

J&J manufactures various healthcare products and currently manages its operations through three segments: Consumer, Medical Devices, and Pharmaceutical.

Also Read: Mynaric AG IPO: Is laser comms firm’s MYNA stock worth considering?

On Friday, the Band-aid, Tylenol, and baby products manufacturer said the decision was taken to keep up with the rapid changes in the healthcare industry.

Johnson & Johnson’s consumer unit has recently been hit by a barrage of lawsuits over its products, including baby powder, linking it to ovarian cancers in some users.

However, the company CEO, Alex Gorsky, stressed the lawsuits have no role in the split.

J&J’s pharmaceutical division has been the strongest performer so far.

In 2020, the drug segment accounted for 55% of its total sales, while the medical instrument and consumer arms contributed 28% and 17% of the total sales, respectively. In addition, the company generated total revenue of US$83 billion last year.

Experts now expect its net sales to be more than US$90 billion in 2021.

Also Read: Five stocks to explore as US marks Veterans Day

Johnson & Johnson (JNJ) is going to split into two companies in the next 18 to 24 months.

Also Read: Walt Disney (DIS) posts a net income of US$159 million in Q4

Split Options

The company is currently considering options for the split.

Johnson & Johnson’s Chief Financial Officer Joseph Wolk said the company is looking for a split option either through "spin or an IPO split," although talks are still in the “early stages.” Wolk added that the company would consider the market conditions before coming to a decision.

Meanwhile, Johnson & Johnson did not provide any financial details for the split but said the transaction would be tax-free. However, the company expects dividends payments to continue at the current level. Wolk said the traders might receive new shares of the consumer firm or might trade stocks of the new health company.

Also Read: Is Affirm (AFRM) stock worth exploring after its stellar Q1 show?

J&J stock performance and company financials

The JNJ stock traded at US$167.70, up 2.85%, at 9:21 am ET on Nov 12, from their previous closing price. The stock value increased by 4.19% YTD.

J&J's market cap is US$429.27 billion, with a P/E ratio and forward P/E one-year of 24.37 and 16.67, respectively. Its EPS is US$6.69, and its share volume on Nov 11 was 4,118,791. The 52-week highest and lowest stock prices were US$179.92 and US$142.86, respectively.

In the third quarter of fiscal 2021, the company's total sales jumped 10.7% YoY to US$23.3 billion, while its net earnings came in at US$3.66 billion, representing an increase of 3.2% from the same quarter of the previous year.

Also Read: Seven green stocks that may give a leg-up to the sector in 2022

Bottomline

Although J&J's consumer segment represented a small fraction of its total revenue, it achieved immense brand recognition. Its split decision comes just days after General Electric announced a similar move to break itself into three public companies, suggesting that they are open to breaking themselves into smaller entities to cope with the rapidly changing business environment and consumer choices.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next